Breast cancer screening may not improve in early medical home implementation.
Phyllis Brawarsky, MPH
Advertisement
Articles by Phyllis Brawarsky, MPH
This study highlights the potential value of innovative ways of collecting information about adverse drug events directly from patients.
Advertisement
Latest Updated Articles
- Medical Home Transformation and Breast Cancer Screening
Published: November 10th 2016 | Updated:
- Active Pharmacovigilance and Healthcare Utilization
Published: November 16th 2012 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
3
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
4
Value-Based Care Interventions and Management of CKD Progression
5
